Intellia Therapeutics, Inc. (NTLA)
USD 8.84
(2.31%)
USD 8.84
(2.31%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -481.19 Million USD | 1.84% |
| 2022 | -490.2 Million USD | -88.75% |
| 2021 | -259.71 Million USD | -106.83% |
| 2020 | -125.56 Million USD | -35.46% |
| 2019 | -92.69 Million USD | -8.62% |
| 2018 | -85.34 Million USD | -26.35% |
| 2017 | -67.54 Million USD | -113.51% |
| 2016 | -31.63 Million USD | -155.17% |
| 2015 | -12.39 Million USD | 13.36% |
| 2014 | -14.3 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -107.43 Million USD | 18.71% |
| 2024 Q2 | -146.97 Million USD | -36.8% |
| 2023 FY | -481.19 Million USD | 1.84% |
| 2023 Q4 | -132.16 Million USD | -8.13% |
| 2023 Q2 | -123.68 Million USD | -33.94% |
| 2023 Q1 | -92.34 Million USD | 20.89% |
| 2023 Q3 | -122.22 Million USD | 1.18% |
| 2022 Q2 | -99.97 Million USD | 31.93% |
| 2022 Q4 | -116.72 Million USD | -3.09% |
| 2022 FY | -490.2 Million USD | -88.75% |
| 2022 Q1 | -146.87 Million USD | -80.79% |
| 2022 Q3 | -113.22 Million USD | -13.26% |
| 2021 Q1 | -46.2 Million USD | -9.51% |
| 2021 FY | -259.71 Million USD | -106.83% |
| 2021 Q4 | -81.23 Million USD | -13.39% |
| 2021 Q3 | -71.64 Million USD | -4.12% |
| 2021 Q2 | -68.8 Million USD | -48.91% |
| 2020 Q3 | -27.84 Million USD | 14.06% |
| 2020 Q2 | -32.39 Million USD | -1.85% |
| 2020 Q1 | -31.8 Million USD | -12.48% |
| 2020 Q4 | -42.19 Million USD | -51.55% |
| 2020 FY | -125.56 Million USD | -35.46% |
| 2019 Q4 | -28.27 Million USD | -19.64% |
| 2019 FY | -92.69 Million USD | -8.62% |
| 2019 Q1 | -21.94 Million USD | -15.07% |
| 2019 Q2 | -25.68 Million USD | -17.06% |
| 2019 Q3 | -23.63 Million USD | 7.98% |
| 2018 Q1 | -21.35 Million USD | 10.88% |
| 2018 FY | -85.34 Million USD | -26.35% |
| 2018 Q4 | -19.06 Million USD | 16.02% |
| 2018 Q3 | -22.7 Million USD | -2.17% |
| 2018 Q2 | -22.21 Million USD | -4.04% |
| 2017 Q3 | -15.35 Million USD | 1.52% |
| 2017 FY | -67.54 Million USD | -113.51% |
| 2017 Q4 | -23.96 Million USD | -56.05% |
| 2017 Q1 | -12.63 Million USD | -19.58% |
| 2017 Q2 | -15.59 Million USD | -23.45% |
| 2016 Q1 | -6.68 Million USD | -27.53% |
| 2016 Q2 | -6.9 Million USD | -3.15% |
| 2016 FY | -31.63 Million USD | -155.17% |
| 2016 Q4 | -10.56 Million USD | -41.18% |
| 2016 Q3 | -7.48 Million USD | -8.43% |
| 2015 Q3 | -3.01 Million USD | 0.69% |
| 2015 FY | -12.39 Million USD | 13.36% |
| 2015 Q4 | -5.24 Million USD | -73.73% |
| 2015 Q1 | -1.09 Million USD | 84.85% |
| 2015 Q2 | -3.04 Million USD | -178.13% |
| 2014 Q2 | -178 Thousand USD | 0.0% |
| 2014 Q4 | -7.21 Million USD | 0.0% |
| 2014 FY | -14.3 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Absci Corporation | -110.56 Million USD | -335.208% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -113.626% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -9.302% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -4737.196% |
| Apollomics, Inc. | -172.6 Million USD | -178.789% |
| 180 Life Sciences Corp. | -19.93 Million USD | -2313.791% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1498.963% |
| Bicycle Therapeutics plc | -180.66 Million USD | -166.346% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -556.049% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -168.743% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -1686.294% |
| Chimerix, Inc. | -82.09 Million USD | -486.14% |
| CRISPR Therapeutics AG | -153.61 Million USD | -213.256% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2217.923% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -579.698% |
| Fortress Biotech, Inc. | -60.63 Million USD | -693.562% |
| Fortress Biotech, Inc. | -60.63 Million USD | -693.562% |
| Gritstone bio, Inc. | -138.49 Million USD | -247.456% |
| Allakos Inc. | -185.7 Million USD | -159.122% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -873.403% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -306.025% |
| Cytokinetics, Incorporated | -526.24 Million USD | 8.561% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -381.592% |
| Innoviva, Inc. | 179.72 Million USD | 367.742% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -6033.436% |
| NLS Pharmaceutics AG | -12.17 Million USD | -3853.26% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -311.987% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -3836333.811% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -433.413% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -482.289% |
| ImmuCell Corporation | -5.77 Million USD | -8232.909% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -325.981% |
| Incyte Corporation | 597.59 Million USD | 180.521% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -256.129% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -7119.794% |
| Mustang Bio, Inc. | -51.6 Million USD | -832.506% |
| MiMedx Group, Inc. | 67.43 Million USD | 813.522% |
| MEI Pharma, Inc. | 17.77 Million USD | 2806.671% |
| MacroGenics, Inc. | -9.05 Million USD | -5212.343% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -5626.979% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1533.041% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -3325.855% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -240.293% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -304.265% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1503.687% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -3758.797% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -4660.978% |
| NextCure, Inc. | -62.72 Million USD | -667.17% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -879.625% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -4718.666% |
| Onconetix, Inc. | -37.4 Million USD | -1186.276% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1118.856% |
| Opthea Limited | -220.24 Million USD | -118.483% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -819.376% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -840.58% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1020.557% |
| Precigen, Inc. | -95.9 Million USD | -401.743% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -1860.608% |
| Prime Medicine, Inc. | -198.13 Million USD | -142.863% |
| PureTech Health plc | -65.69 Million USD | -632.441% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -95.929% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 112.171% |
| Replimune Group, Inc. | -215.79 Million USD | -122.987% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -400046.357% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -1817.787% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -2494.573% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -10.272% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1877.017% |
| Sesen Bio, Inc. | -19.88 Million USD | -2319.996% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -86.631% |
| Solid Biosciences Inc. | -96.01 Million USD | -401.163% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -129.84% |
| SciSparc Ltd. | -5.12 Million USD | -9294.611% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -350.584% |
| TG Therapeutics, Inc. | 12.67 Million USD | 3897.285% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -312.481% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -8540.546% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -331.954% |
| UroGen Pharma Ltd. | -102.24 Million USD | -370.631% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -618.251% |
| XOMA Corporation | -40.83 Million USD | -1078.497% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -64.684% |
| AbCellera Biologics Inc. | -146.39 Million USD | -228.688% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -784.187% |
| Cassava Sciences, Inc. | -97.21 Million USD | -394.967% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -978.826% |
| Precision BioSciences, Inc. | -61.31 Million USD | -684.736% |
| Dyadic International, Inc. | -6.79 Million USD | -6981.08% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -4466.255% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -51309.402% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1591.241% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -287.795% |
| IGM Biosciences, Inc. | -246.41 Million USD | -95.276% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -375.641% |
| Acelyrin, Inc. | -381.64 Million USD | -26.085% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -788.005% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1022.637% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -2428.745% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1518.812% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -192.386% |
| Senti Biosciences, Inc. | -92.91 Million USD | -417.862% |
| Mesoblast Limited | -87.95 Million USD | -447.083% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -227.426% |
| ChromaDex Corporation | -4.93 Million USD | -9644.674% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -9942.688% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -826.706% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -6073.331% |
| Seer, Inc. | -86.27 Million USD | -457.729% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -672.937% |
| Novavax, Inc. | -545.06 Million USD | 11.718% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -3067.924% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -199.011% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -828.1% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -105.084% |
| Celcuity Inc. | -63.77 Million USD | -654.466% |
| ContextLogic Inc. | -317 Million USD | -51.796% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -138.696% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -489.841% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 215.997% |
| Amarin Corporation plc | -59.11 Million USD | -714.034% |
| AnaptysBio, Inc. | -163.61 Million USD | -194.093% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -2663.724% |
| Aptorum Group Limited | -2.82 Million USD | -16935.474% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -119.012% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -134.413% |
| Ardelyx, Inc. | -66.06 Million USD | -628.339% |
| Celularity Inc. | -196.29 Million USD | -145.137% |
| Omeros Corporation | -117.81 Million USD | -308.437% |
| Humacyte, Inc. | -110.77 Million USD | -334.383% |
| Immunocore Holdings plc | -55.28 Million USD | -770.353% |
| IO Biotech, Inc. | -86.08 Million USD | -458.986% |
| GT Biopharma, Inc. | -7.59 Million USD | -6233.974% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -611.034% |
| Summit Therapeutics Inc. | -614.92 Million USD | 21.748% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1269.357% |
| Pulmatrix, Inc. | -14.12 Million USD | -3307.634% |
| Evogene Ltd. | -23.87 Million USD | -1915.126% |
| CorMedix Inc. | -46.33 Million USD | -938.412% |
| BioLineRx Ltd. | -60.61 Million USD | -693.863% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1538.826% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1626.187% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 23.206% |
| scPharmaceuticals Inc. | -54.81 Million USD | -777.927% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -394.367% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 553.356% |
| NLS Pharmaceutics AG | -12.17 Million USD | -3853.26% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1877.017% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -217.076% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1270.176% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2208.983% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -359.596% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -521.791% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -715.819% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -2648.704% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1495.391% |
| bluebird bio, Inc. | -211.91 Million USD | -127.071% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 387.03% |
| DBV Technologies S.A. | -72.72 Million USD | -561.651% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -126.742% |
| Galecto, Inc. | -38.34 Million USD | -1154.771% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1311.079% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -904.178% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -99.366% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1204.064% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -83.563% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1603.998% |
| Clene Inc. | -49.5 Million USD | -872.027% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -46.675% |
| Aptose Biosciences Inc. | -51.2 Million USD | -839.7% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -389.524% |
| Soligenix, Inc. | -6.14 Million USD | -7736.072% |
| Century Therapeutics, Inc. | -136.67 Million USD | -252.075% |
| Kura Oncology, Inc. | -152.63 Million USD | -215.265% |
| Surrozen, Inc. | -43.04 Million USD | -1017.959% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -439.344% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 85195.938% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -84468.014% |
| Autolus Therapeutics plc | -208.38 Million USD | -130.917% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -569.27% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -2120.749% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -371.433% |
| GRI Bio, Inc. | -13.03 Million USD | -3590.972% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -11538.237% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -725.471% |
| INmune Bio, Inc. | -30 Million USD | -1503.546% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -335.235% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1040.433% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -2914.674% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -6140.597% |
| Jaguar Health, Inc. | -41.3 Million USD | -1065.114% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -2946.486% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -706.219% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1381.274% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -74.265% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -102.273% |
| Verastem, Inc. | -87.36 Million USD | -450.771% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -198.255% |
| Histogen Inc. | -10.62 Million USD | -4430.572% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -3268.098% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -685.158% |
| Surrozen, Inc. | -43.04 Million USD | -1017.959% |
| Organovo Holdings, Inc. | -14.67 Million USD | -3179.885% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -9359.195% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -5657.892% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -218.491% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -883.509% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -4518.983% |
| Kronos Bio, Inc. | -112.67 Million USD | -327.069% |
| Turnstone Biologics Corp. | -55.2 Million USD | -771.725% |
| Synaptogenix, Inc. | -6.03 Million USD | -7868.729% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -2868.855% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -7098.085% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -516.755% |
| Exelixis, Inc. | 207.76 Million USD | 331.604% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -234.282% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 8.973% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -646.439% |
| ESSA Pharma Inc. | -26.58 Million USD | -1710.194% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -11929.95% |
| Avid Bioservices, Inc. | -140.75 Million USD | -241.87% |
| Insmed Incorporated | -749.56 Million USD | 35.804% |
| MediWound Ltd. | -6.71 Million USD | -7064.86% |
| OmniAb, Inc. | -50.61 Million USD | -850.615% |
| Alector, Inc. | -130.39 Million USD | -269.038% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -323.123% |
| Zai Lab Limited | -334.62 Million USD | -43.803% |
| AlloVir, Inc. | -190.41 Million USD | -152.703% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -48.522% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -377.861% |
| Aura Biosciences, Inc. | -76.4 Million USD | -529.767% |
| Immunic, Inc. | -93.61 Million USD | -414.028% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -254.096% |
| Veracyte, Inc. | -74.4 Million USD | -546.729% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -6169.153% |
| FibroGen, Inc. | -284.23 Million USD | -69.296% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1734.37% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 773.844% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -6772.316% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -2455.089% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -2033.416% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1076.623% |
| Fortrea Holdings Inc. | -3.4 Million USD | -14052.706% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -279.956% |
| XBiotech Inc. | -24.55 Million USD | -1859.49% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -646.439% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -214.521% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1188.677% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -667.696% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -388.887% |
| Agenus Inc. | -245.76 Million USD | -95.797% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -2145.727% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -771.835% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 20.679% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -604.992% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -112.41% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -2060.959% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -263.183% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -9002.152% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -1886.673% |
| Lantern Pharma Inc. | -15.96 Million USD | -2914.698% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1093.255% |
| Ainos, Inc. | -13.77 Million USD | -3394.356% |
| Pluri Inc. | -20.88 Million USD | -2203.677% |
| Prothena Corporation plc | -147.02 Million USD | -227.279% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -322.576% |
| Rallybio Corporation | -74.56 Million USD | -545.341% |
| Kodiak Sciences Inc. | -260.49 Million USD | -84.725% |
| Cue Biopharma, Inc. | -50.73 Million USD | -848.479% |
| MeiraGTx Holdings plc | -84.02 Million USD | -472.664% |
| Annexon, Inc. | -134.23 Million USD | -258.465% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -685.902% |
| Moderna, Inc. | -4.71 Billion USD | 89.792% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -2575.667% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -1998.434% |
| Blueprint Medicines Corporation | -506.98 Million USD | 5.087% |
| Immix Biopharma, Inc. | -15.42 Million USD | -3019.347% |
| CalciMedica, Inc. | -34.35 Million USD | -1300.565% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -255.512% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -190.244% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -736.666% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -69.879% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1267.217% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -358.842% |
| Nutriband Inc. | -5.48 Million USD | -8672.369% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1090.48% |
| Vor Biopharma Inc. | -117.86 Million USD | -308.264% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 111.065% |
| Alkermes plc | 355.75 Million USD | 235.259% |
| ProKidney Corp. | -35.46 Million USD | -1256.693% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -301.787% |
| Arcellx, Inc. | -70.69 Million USD | -580.707% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 25.188% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -372.944% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1071.753% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1096.281% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -496.641% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -537.163% |
| MediciNova, Inc. | -8.57 Million USD | -5513.849% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -290.334% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -5644.318% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1753.107% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -101.135% |
| Biomea Fusion, Inc. | -117.25 Million USD | -310.381% |
| RenovoRx, Inc. | -10.23 Million USD | -4602.815% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -214.172% |
| Geron Corporation | -184.12 Million USD | -161.337% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1495.993% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -377.198% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -103.949% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 3516.586% |
| Royalty Pharma plc | 1.13 Billion USD | 142.402% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -149.371% |
| Imunon, Inc. | -19.51 Million USD | -2365.757% |
| BioAtla, Inc. | -123.46 Million USD | -289.749% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -47.034% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1202.314% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -180.301% |
| Structure Therapeutics Inc. | -89.62 Million USD | -436.925% |
| 89bio, Inc. | -142.18 Million USD | -238.417% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -372.359% |
| aTyr Pharma, Inc. | -50.38 Million USD | -854.954% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -448.811% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -102.408% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -5846.559% |
| Akari Therapeutics, Plc | -10 Million USD | -4708.074% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -714630.041% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 270.881% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -171.677% |
| Liquidia Corporation | -78.5 Million USD | -512.968% |
| Entera Bio Ltd. | -8.88 Million USD | -5313.342% |
| GH Research PLC | -35.58 Million USD | -1252.157% |
| Vericel Corporation | -3.18 Million USD | -15022.313% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -560.533% |
| Xencor, Inc. | -126.08 Million USD | -281.635% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -12678.281% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -2914.674% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -2162.672% |
| Vaxcyte, Inc. | -402.26 Million USD | -19.62% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -163.822% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 19278.637% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -7119.794% |
| Portage Biotech Inc. | -75.33 Million USD | -538.702% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -5644.318% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -397.845% |
| OncoCyte Corporation | -27.78 Million USD | -1632.09% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -3486.378% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -4226.675% |
| Purple Biotech Ltd. | -19.88 Million USD | -2320.483% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1531.657% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -1666.62% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -160.557% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -6755.563% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1516.42% |
| United Therapeutics Corporation | 984.8 Million USD | 148.862% |
| HilleVax, Inc. | -123.56 Million USD | -289.421% |
| Silo Pharma, Inc. | -3.7 Million USD | -12902.789% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -3581.128% |
| Pharming Group N.V. | -10.54 Million USD | -4461.926% |
| Tharimmune, Inc. | -9.31 Million USD | -5063.506% |
| Genprex, Inc. | -30.86 Million USD | -1459.251% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -472.95% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -103.96% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -552.11% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -26902.918% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -8985.926% |
| OKYO Pharma Limited | -16.82 Thousand USD | -2859803.979% |
| Savara Inc. | -54.69 Million USD | -779.725% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -2271.455% |
| Curis, Inc. | -47.41 Million USD | -914.895% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -3015.502% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1513.926% |
| BeiGene, Ltd. | -881.7 Million USD | 45.425% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -509.451% |
| Erasca, Inc. | -125.04 Million USD | -284.824% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -9522.883% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -9522.883% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1098.277% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -8350.861% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -696.834% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -240.236% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -150.087% |
| Adicet Bio, Inc. | -142.65 Million USD | -237.305% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -217.442% |
| Aditxt, Inc. | -32.38 Million USD | -1386.039% |
| Adagene Inc. | -18.94 Million USD | -2439.758% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6481.103% |
| Quantum-Si incorporated | -95.96 Million USD | -401.451% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3200.862% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 463.63% |
| Compugen Ltd. | -18.75 Million USD | -2465.81% |
| Generation Bio Co. | -126.61 Million USD | -280.052% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -560.153% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -483.673% |
| Invivyd, Inc. | -198.64 Million USD | -142.24% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -40.711% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -5439.492% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2209.936% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -4773.324% |
| 2seventy bio, Inc. | -217.57 Million USD | -121.167% |
| Instil Bio, Inc. | -156.08 Million USD | -208.284% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -2059.018% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -11086.565% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1753.107% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1378.638% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -387.077% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -199.239% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 21.765% |
| Evaxion Biotech A/S | -22.12 Million USD | -2074.879% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -496.007% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -140.514% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -596.028% |
| Cingulate Inc. | -23.53 Million USD | -1944.585% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -6861.69% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1107.205% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -708.685% |
| Clearmind Medicine Inc. | -11.95 Million USD | -3925.017% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -595.394% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -18972627.237% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -460.21% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -28.788% |
| ImmunityBio, Inc. | -583.19 Million USD | 17.491% |
| Korro Bio, Inc. | -81.17 Million USD | -492.805% |
| Kineta, Inc. | -14.09 Million USD | -3312.951% |
| BioVie Inc. | -32.12 Million USD | -1398.082% |
| Codexis, Inc. | -76.24 Million USD | -531.154% |
| Celularity Inc. | -196.29 Million USD | -145.137% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -2958.683% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -124.302% |
| Virax Biolabs Group Limited | -6.73 Million USD | -7046.2% |
| Cibus, Inc. | -267.62 Million USD | -79.799% |
| IN8bio, Inc. | -30 Million USD | -1503.599% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -310.696% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1425.463% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -31.371% |
| Eyenovia, Inc. | -27.26 Million USD | -1665.123% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 2328.669% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -89842.43% |
| Elevation Oncology, Inc. | -45.7 Million USD | -952.844% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -529.799% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1061.15% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -259.592% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1501.998% |
| Moolec Science SA | -51.78 Million USD | -829.142% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -818.814% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1046.405% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -253.932% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1032.376% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -5311.636% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -2165.154% |
| Humacyte, Inc. | -110.77 Million USD | -334.383% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -597.784% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -4537.101% |
| Genelux Corporation | -28.29 Million USD | -1600.505% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1555.572% |
| Notable Labs, Ltd. | -11.26 Million USD | -4171.946% |
| Immunovant, Inc. | -259.33 Million USD | -85.548% |
| Quantum-Si incorporated | -95.96 Million USD | -401.451% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -2382.803% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -401.294% |
| Acasti Pharma Inc. | -12.85 Million USD | -3643.811% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -2042.644% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1134.205% |
| PepGen Inc. | -78.62 Million USD | -512.001% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -2061.689% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -9942.688% |
| Immuneering Corporation | -53.47 Million USD | -799.902% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -9359.195% |
| Belite Bio, Inc | -31.63 Million USD | -1421.219% |
| XOMA Corporation | -40.83 Million USD | -1078.497% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -785.114% |
| Bionomics Limited | -15.49 Billion USD | 96.894% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1550.348% |
| uniQure N.V. | -308.47 Million USD | -55.989% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6481.103% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -289.85% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1428.758% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -5766.977% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1555.401% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -89842.43% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1734.37% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -2818.969% |
| Altimmune, Inc. | -88.44 Million USD | -444.046% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -286.031% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1550.348% |
| Peak Bio, Inc. | -1259.26 USD | -38212183.405% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -944.956% |
| Benitec Biopharma Inc. | -21.75 Million USD | -2112.275% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -42.033% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -480.071% |
| Zura Bio Limited | -60.36 Million USD | -697.203% |
| PolyPid Ltd. | -23.86 Million USD | -1916.308% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -480.071% |
| argenx SE | -295.05 Million USD | -63.087% |
| Immunome, Inc. | -106.8 Million USD | -350.529% |
| Verona Pharma plc | -54.36 Million USD | -785.048% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -381.592% |
| Shattuck Labs, Inc. | -87.29 Million USD | -451.206% |
| CervoMed Inc. | -2.17 Million USD | -22055.623% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -3513.638% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1004.792% |
| Moolec Science SA | -51.78 Million USD | -829.142% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -2782686.916% |
| Design Therapeutics, Inc. | -66.86 Million USD | -619.679% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -491.043% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1170.239% |
| Achilles Therapeutics plc | -69.66 Million USD | -590.723% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -18972627.237% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -889.964% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -524.187% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1316.52% |
| MoonLake Immunotherapeutics | -36 Million USD | -1236.375% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1042.323% |
| Beam Therapeutics Inc. | -132.52 Million USD | -263.09% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -194.46% |
| AEON Biopharma, Inc. | -52.55 Million USD | -815.58% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -631.684% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -572.206% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -3745.261% |
| NeurAxis, Inc. | -14.62 Million USD | -3189.823% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -8.368% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1313.857% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 16092.874% |
| Palisade Bio, Inc. | -12.3 Million USD | -3812.13% |
| Nutriband Inc. | -5.48 Million USD | -8672.369% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -331.307% |
| Neurogene Inc. | -36.31 Million USD | -1224.977% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -5560.416% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -390.277% |
| Athira Pharma, Inc. | -117.67 Million USD | -308.927% |
| HCW Biologics Inc. | -24.99 Million USD | -1825.209% |
| XOMA Corporation | -40.83 Million USD | -1078.497% |
| Nektar Therapeutics | -276.05 Million USD | -74.31% |
| Arvinas, Inc. | -367.3 Million USD | -31.008% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -714630.041% |
| Merus N.V. | -154.93 Million USD | -210.569% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -393.895% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1433.191% |
| Rezolute, Inc. | -68.45 Million USD | -602.891% |
| Clene Inc. | -49.5 Million USD | -872.027% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3019.868% |
| BeyondSpring Inc. | -21.02 Million USD | -2188.557% |
| Synlogic, Inc. | -57.28 Million USD | -740.041% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -3943.29% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4344.781% |
| Peak Bio, Inc. | -1259.26 USD | -38212183.405% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1187.711% |
| Krystal Biotech, Inc. | 10.93 Million USD | 4501.683% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -236.265% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -48.012% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -10317.745% |
| MannKind Corporation | -11.93 Million USD | -3930.759% |
| Ikena Oncology, Inc. | -68.16 Million USD | -605.912% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -2189.755% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -417.784% |
| Gossamer Bio, Inc. | -179.81 Million USD | -167.601% |
| CohBar, Inc. | -11.96 Million USD | -3922.632% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1765.953% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1495.993% |
| Legend Biotech Corporation | -518.25 Million USD | 7.151% |
| Mural Oncology plc | -207.44 Million USD | -131.959% |
| Disc Medicine, Inc. | -76.42 Million USD | -529.593% |
| Champions Oncology, Inc. | -7.27 Million USD | -6513.414% |
| REGENXBIO Inc. | -263.49 Million USD | -82.62% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -4433.955% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -912.929% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1166.845% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -380.409% |
| Vaxart, Inc. | -82.46 Million USD | -483.511% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 144271.763% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1181.726% |
| Cellectis S.A. | -101.05 Million USD | -376.15% |
| Longeveron Inc. | -21.41 Million USD | -2147.196% |
| Repare Therapeutics Inc. | -93.79 Million USD | -413.02% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 10.222% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -576.126% |
| Revolution Medicines, Inc. | -436.36 Million USD | -10.272% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -7222.965% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1461.095% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -594.03% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -643.36% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -4804.617% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 113.294% |
| Denali Therapeutics Inc. | -145.22 Million USD | -231.345% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -400046.357% |
| Veru Inc. | -93.15 Million USD | -416.563% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -1680.28% |
| Cingulate Inc. | -23.53 Million USD | -1944.585% |
| Passage Bio, Inc. | -102.06 Million USD | -371.47% |
| Context Therapeutics Inc. | -23.96 Million USD | -1907.961% |
| Exicure, Inc. | -16.91 Million USD | -2744.933% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -154.711% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1174.208% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -7294.621% |
| Nuvalent, Inc. | -126.21 Million USD | -281.236% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -4475.958% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -453.865% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1475.406% |
| OmniAb, Inc. | -50.61 Million USD | -850.615% |
| Anew Medical, Inc. | 1.34 Million USD | 35846.457% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -2899.015% |
| Lipocine Inc. | -16.35 Million USD | -2842.696% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -624.752% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -655.7% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1040.433% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -903.173% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -2326.464% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 11.135% |
| Ocugen, Inc. | -63.07 Million USD | -662.852% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -402.645% |
| Q32 Bio Inc. | -112.96 Million USD | -325.981% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -2698.93% |
| Alumis Inc. Common Stock | -154.99 Million USD | -210.46% |
| Equillium, Inc. | -13.33 Million USD | -3508.489% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -697.124% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -5924.06% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -2452.577% |
| Dominari Holdings Inc. | -22.88 Million USD | -2002.928% |
| Edesa Biotech, Inc. | -8.37 Million USD | -5645.977% |
| vTv Therapeutics Inc. | -20.25 Million USD | -2276.257% |
| Bio-Techne Corporation | 168.1 Million USD | 386.245% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -36.668% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 473.443% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -294.964% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1168.331% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -327.187% |
| Nkarta, Inc. | -117.5 Million USD | -309.522% |
| BioCardia, Inc. | -11.57 Million USD | -4058.603% |
| Iterum Therapeutics plc | -38.37 Million USD | -1154.051% |